Inventor
WICKHAM THOMAS
US14 patents
⚠️ This page may combine multiple inventors who share the name “WICKHAM THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERRIMACK PHARMACEUTICALS INC
7 patentsUS9718892B2Aug 1, 2017
Method of treating myocardial infarction by administering a bi-specific fusion protein
MERRIMACK PHARMACEUTICALS INC12 citations92
US9982060B2May 29, 2018
Bi-specific fusion proteins
MERRIMACK PHARMACEUTICALS INC9 citations91
US9511155B2Dec 6, 2016
Compositions and methods for non-invasive imaging
MERRIMACK PHARMACEUTICALS INC10 citations81
US9226966B2Jan 5, 2016
Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
MERRIMACK PHARMACEUTICALS INC2 citations54
US9968694B2May 15, 2018
Compositions and methods for non-invasive imaging
MERRIMACK PHARMACEUTICALS INC0 citations49
US9913901B2Mar 13, 2018
Combination therapy for treating HER2-positive cancers
MERRIMACK PHARMACEUTICALS INC0 citations45
US9610249B2Apr 4, 2017
Dosage and administration for preventing cardiotoxicity in treatment with ERbB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
MERRIMACK PHARMACEUTICALS INC0 citations44
SILVER CREEK PHARMACEUTICALS INC
5 patentsUS10407512B2Sep 10, 2019
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC9 citations91
US10988547B2Apr 27, 2021
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC6 citations83
US10858450B2Dec 8, 2020
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC6 citations82
US11814443B2Nov 14, 2023
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC1 citations72
US11673970B2Jun 13, 2023
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC1 citations71